Hinova Pharmaceuticals Inc. A

SHG:688302 China Biotechnology

Market Cap

$558.69 Million

CN¥4.10 Billion CNY

Market Cap Rank

#11394 Global

#2664 in China

Share Price

CN¥41.40

Change (1 day)

-0.72%

52-Week Range

CN¥32.07 - CN¥67.20

All Time High

CN¥74.97

Hinova Pharmaceuticals Inc. A - Asset Resilience Ratio

Latest as of June 2025: 15.84%

Hinova Pharmaceuticals Inc. A (688302) has an Asset Resilience Ratio of 15.84% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥220.52 Million

Cash + Short-term Investments

Total Assets

CN¥1.39 Billion

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Hinova Pharmaceuticals Inc. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Hinova Pharmaceuticals Inc. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥220.52 Million	15.84%
Total Liquid Assets	CN¥220.52 Million	15.84%

Asset Resilience Insights

Good Liquidity Position: Hinova Pharmaceuticals Inc. A maintains a healthy 15.84% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.